Notably, companies, such as Amway (US), Bayer (Germany), and Abbott (US) are focusing on tech-driven personalized nutrition and supplements. For instance, in June 2025, Abbott (US) initiated a new research program (The Healthy Food Rx Program) to deliver personalized meal-based food boxes to the patients with diabetes, offering nutrition education to improve overall health outcomes. This research shows that participants experienced improvement in physical health and achieve greater satisfaction...

The global digital twin market size is estimated to grow from $12.8 billion in 2024 to $240.3 billion in 2035, growing at a CAGR of 30.54% during the forecast period, till 2035. The growth of digital twin market is driven by a number of key factors. For instance, the growing adoption of IoT technology has enabled the development of intricate digital replicas of various industrial processes, assets and systems. This technology, coupled with artificial intelligence and machine learning, has enable...

The global viral vector manufacturing market, valued at USD 704 million in 2024, is estimated to reach USD 799 million in 2025 and USD 2,315 million by 2035, representing a CAGR of 11.23% during the forecast period. Over the past few years, these vectors have emerged as the key pre-requisites for cell and gene therapy manufacturing. It is worth mentioning that, till January 2023, over 25 viral vector based gene therapy products have been approved by different regulatory agencies, worldwide. In t...

Several market players have shown active interest in the field to initiate technological innovations. The primary focus of industrial players is on the development of computational tools, such as CRISPR gene editing for the modification of genetic material. For instance, in February 2025, researchers team at MIT’s McGovern Institute and the Broad Institute of MIT and Harvard found TIGR (Tandem Interspaced Guide RNA), an RNA guides system with diverse functionalities in gene editing. The consi...

The global plant based protein expression market, valued at USD 2.42 billion in 2025, is projected to reach USD 2.98 billion in 2026 and USD 5.81 billion by 2035, with a 7.68% CAGR during the forecast period 2026 to 2035. It is worth highlighting that our research indicates that the existing mammalian cell capacities are likely to fulfill only 50% of the inflated demand (due to COVID-19) for biologics. In this context, plant based expression systems have emerged as a promising alternative fo...

The biologics fill finish manufacturing market, valued at USD 4.4 billion in 2025, is projected to reach USD 4.7 billion in 2026 and USD 8.4 billion by 2035, representing a CAGR of 6.71%, during the forecast period 2026 to 2035. Through our new market research study, we have identified the key market trends, competitive landscape, market forecast and opportunity for biologics fill finish service providers. The biologics fill finish manufacturing market growth over the next decade is expected to...

Several industrial players are increasing initiatives for innovations and expanding its application in healthcare. For instance, in June 2025, a latest Neoplas Argon Jet system, a cold plasma device developed through a German European scientific collaboration led by Leibniz Institute for Plasma Science and Technology and Neoplas Med (Germany) has been launched in Oman. This newly launched Neoplas Argon Jet system offers a non-invasive alternative treatment to treat infections. These innovations...

The exosomes development and exosomes manufacturing market, valued at USD 24.2 million in 2025, is projected to reach USD 28.6 million in 2026 and USD 127.4 million by 2035, with a 18.1% CAGR during the forecast period 2026 to 2035. Over time, various research studies have demonstrated the potential of isolated exosomes in disease diagnosis and drug delivery applications, owing to their ability to act as biomarkers for various diseases and transport important functional elements. Presently, seve...

Several market players, and numerous research organizations are accelerating their research on avian influenza vaccine, which is expected to be a key driver for the avian influenza vaccine market.For instance, in April 2025, The University of Cambridge–based DioSynVax and Singapore's ACM Biolabs have signed a strategic deal to jointly develop a next-generation universal avian flu vaccine. In addition to strategic partnerships, regulatory authorities are initiating vaccination programs to mitig...

Market players, such as Cutera, Fotona, and InMode are leveraging strategic initiatives, followed by latest product approval, collaborations and partnerships. For instance, in May 2025, Apyx® Medical announced that its AYON Body Contouring System™ has received 510(k) clearance from the USFDA for fat reduction and body contouring. As more market players continue to explore new technologies, we believe that fat cavitation market will remain progressive in the future.

The global ADC technology market, valued at USD 2.34 billion in 2025, is projected to reach USD 3.44 billion in 2026 and USD 9.51 billion by 2040, representing a 7.5% CAGR during the forecast period 2026 to 2040. According to our projections, North America is likely to capture majority of the ADC technology market share in the current year. However, the market in Asia-Pacific is likely to grow at a relatively faster pace till 2040. The growth is being propelled by the presence of robust ADC phar...

The RNA sequencing service market, valued at USD 3.3 billion in 2025, is projected to reach USD 3.6 billion in 2026 and USD 7.5 billion by 2035, with a 8.5% CAGR during the forecast period 2026 to 2035. RNA sequencing was first introduced by Fredrick Sanger in 1977, who used chain termination method, also known sanger sequencing method / first generation sequencing method. Over time, RNA sequencing service market has witnessed several technological advancements, and different methods of RNA seq...

These 3D cell culture models and organoids are used for studying drug safety and efficacy. In addition to clinical studies, the growing focus on stem cell therapy and regenerative medicine has further bolstered the demand for advanced 3D cell cultures and organoids.Considering the significances of advanced technology-based models, several industrial players are aiming to develop advanced organoid technologies and platforms for drug discovery and clinical studies. For instance, in July 2025, MD A...

The global genotoxicity testing market, valued at USD 1.4 billion in 2025, is projected to reach USD 1.5 billion in 2026 and USD 2.7 billion by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. Genotoxicity refers to the property of hazardous (physical, chemical and biological) agents to cause damage to genetic information present within a cell. At present, more than 80 industry and non-industry players offer a variety of assays, such as Ames assay, micronucleus assay, chromosomal...

Several research programs are underway to develop advanced epigenetic therapies for targeting cancer or solid tumors. For instance, in January 2025, a study published in John Hopkins Medicine highlighted that a team of researchers at Johns Hopkins Kimmel Cancer Center and Chinese Academy of Sciences identify new epigenetic approach to target colorectal cancer. During this study, researchers found a mouse protein that disrupts cancer-causing chemicals within genes associated with colorectal cance...

the market for veterinary digital pathology is also driven by the rising adoption of companion animals, and willing of pet owners to spend on their companion animals health. Considering the rising opportunities, several market players have shown active interest in the field for digital pathology innovations. For instance, in June 2025, MUSE Microscopy (US) launched MUSE veterinary digital pathology, the first-of-its-kind tissue-to-direct digital imaging to provide same-day result for tissue biop...

The global genome editing market, valued at $4.25 billion in 2025, is projected to reach $5.29 billion in 2026 and $13.36 billion by 2035, representing a CAGR of 10.8% during the forecast period 2026 to 2035. more than 1,100 active clinical trials are evaluating gene therapies across various phases of clinical studies. According to the World Health Organization (WHO), 10 out of every 1,000 individuals are affected by genetic disorders, with over 70 million people worldwide living with such condi...

The AI-driven personalized nutrition has been further bolstered by the rising adoption of medical wearable devices, and smartphones that help to collect vital information for disease monitoring and management. Moreover, AI integration with nutrigenomics can help in determining vast amount of data generated through genomics, and metabolomics. Notably, this field is at the forefront of innovation, catering the attention of industrial players.For instance, in February 2025, Fay (US), a digital nutr...

The global non-viral drug delivery systems market, valued at USD 8.6 billion in 2025, is projected to reach USD 11.3 billion in 2026 and USD 20.4 billion by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. In September 2024, NanoSyrinx raised USD 13 million in a seed funding round, in order to advance its intracellular nanosyringe technology that is aimed to target biologics to the sites that are difficult to target within the cell. The market report presents an in-depth analysis...

The global KRAS market size, valued at USD 476 million in 2024, is projected to reach USD 557 million in 2025 and USD 3,894 million by 2035, representing a CAGR of 21% during the forecast period. One of these oncogenic mutations is KRAS, which was identified to be associated with nearly 30% of cancer in humans. One of the key objectives of KRAS market report was to estimate the current market size, opportunity and the market growth potential, over the forecast period, till 2035. We have provided...